Kolexia
Edan Gilles
Neurologie
Hôpital Pontchaillou
Rennes, France
286 Activités
1 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Sclérose en plaques récurrente-rémittente Maladies démyélinisantes Sclérose en plaques chronique progressive COVID-19 Leucoencéphalopathies Inflammation Leucoencéphalopathie multifocale progressive

Industries

Merck-Serono
10 collaboration(s)
Dernière en 2023
Novartis
8 collaboration(s)
Dernière en 2022
Merck
2 collaboration(s)
Dernière en 2020
Biogen
1 collaboration(s)
Dernière en 2022

Dernières activités

RESPONSE: French Registry for Monitoring Pregnancies and Children of Women With Multiple Sclerosis Within The Observatoire Français de la Sclérose en Plaque (OFSEP) Cohort
Essai Clinique (Hospices Civils de Lyon)   25 janvier 2024
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS): Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical Trials (CLASSIC-MS)
Essai Clinique (Emd Serono)   26 octobre 2023
TOTEM-RRMS: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
Essai Clinique (Grünenthal)   23 octobre 2023
Impact of automatic tools for detecting new lesions on therapeutic strategies offered to patients with MS by neurologists.
Multiple sclerosis and related disorders   20 octobre 2023
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
Drugs   19 septembre 2023
Dyadic coping strategies and quality of care experience: An original study of patients living with multiple sclerosis and their caregivers.
Revue neurologique   15 septembre 2023
A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.
Neurodegenerative disease management   03 août 2023
NeurofilMS: Serum Neurofilament-light Chain and Glial Fibrillary Acidic Proten (GFAP) Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
Essai Clinique (CHU Nîmes)   03 mai 2023
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
Multiple sclerosis (Houndmills, Basingstoke, England)   03 avril 2023
PRIMUS-Alpha : prototype de médecine de précision dans la sclérose en plaques contextualisant l’évolution des patients dans des données de référence multi-sources
Journées de Neurologie de Langue Française 2023   01 avril 2023